Part of brain network much bigger in people with depression, scientists find
Researchers found that the frontostriatal salience network is 73% larger in depressed individuals, potentially indicating a risk factor for depression, with implications for early intervention and personalized treatments.
Read original articleResearchers have discovered that individuals with depression have a significantly larger frontostriatal salience network in their brains, which is involved in processing rewards and threats. This network was found to be, on average, 73% larger in depressed individuals compared to healthy controls. The study, published in the journal Nature, utilized advanced brain imaging techniques to analyze fMRI scans from 141 people with depression and 37 without. The findings suggest that this expansion may be a risk factor for developing depression rather than a consequence of the condition. Additionally, the study indicated that brain signals within this network became less synchronized during certain depressive symptoms, correlating with the severity of future symptoms. Notably, scans of children who later developed depression showed this network was already enlarged years before symptoms appeared. While the study raises questions about the genetic or experiential origins of this brain network expansion, it offers potential pathways for identifying individuals at risk for depression and developing personalized treatments. Experts in the field have acknowledged the significance of these findings, emphasizing the need for further research to explore the implications for early intervention and treatment strategies.
- The frontostriatal salience network is 73% larger in individuals with depression.
- The expansion of this brain network may indicate a risk factor for developing depression.
- Brain signal synchronization within the network decreases with certain depressive symptoms.
- Enlarged network observed in children who later develop depression, suggesting early risk identification.
- Further research is needed to explore treatment implications and the origins of the network expansion.
Related
Why don't we know how antidepressants work yet?
Researchers at Imperial College London study antidepressants using 'mini-brain' organoids. SSRIs' effectiveness, mechanisms, and controversies are debated, with focus on biochemical vs. social perspectives. Optimism exists for future antidepressant advancements.
Psilocybin Desynchronizes the Human Brain
A 2024 Nature study shows psilocybin disrupts human brain connectivity, affecting the default mode network significantly. This research suggests therapeutic potential by altering brain connections, notably between the hippocampus and default mode network.
Youth with conduct disorder show widespread differences in brain structure
A NIH-funded neuroimaging study in The Lancet Psychiatry reveals brain structure variations in youth with conduct disorder, impacting behavior and cognition. Reduced cortex area and subcortical volume suggest potential diagnostic and treatment advancements.
Serotonin changes how people learn and respond to negative information
A University of Oxford study found that increased serotonin levels reduce sensitivity to negative outcomes while improving behavioral control and memory, suggesting potential implications for treating depression and mental health disorders.
Depression has a consistent mark in the brain even when symptoms are absent
A study in Nature reveals that the salience network is nearly twice as large in individuals with depression, suggesting a stable biological marker for depression and potential early identification in children.
I skimmed the article in an attempt to figure out whether the topological size increase was due to distance between neurons or denser connections between neurons. Turns out it was both! Big brain moment over here.
Related
Why don't we know how antidepressants work yet?
Researchers at Imperial College London study antidepressants using 'mini-brain' organoids. SSRIs' effectiveness, mechanisms, and controversies are debated, with focus on biochemical vs. social perspectives. Optimism exists for future antidepressant advancements.
Psilocybin Desynchronizes the Human Brain
A 2024 Nature study shows psilocybin disrupts human brain connectivity, affecting the default mode network significantly. This research suggests therapeutic potential by altering brain connections, notably between the hippocampus and default mode network.
Youth with conduct disorder show widespread differences in brain structure
A NIH-funded neuroimaging study in The Lancet Psychiatry reveals brain structure variations in youth with conduct disorder, impacting behavior and cognition. Reduced cortex area and subcortical volume suggest potential diagnostic and treatment advancements.
Serotonin changes how people learn and respond to negative information
A University of Oxford study found that increased serotonin levels reduce sensitivity to negative outcomes while improving behavioral control and memory, suggesting potential implications for treating depression and mental health disorders.
Depression has a consistent mark in the brain even when symptoms are absent
A study in Nature reveals that the salience network is nearly twice as large in individuals with depression, suggesting a stable biological marker for depression and potential early identification in children.